Gland Surgery 2024 CiteScore Released: 3.1

We are pleased to announce that the Gland Surgery (GS) has achieved its 2024 CiteScore: 3.1, ranking 184 out of 568 journals in the Surgery category. This milestone underscores our ongoing commitment to publishing impactful research in the field.

Read More>>

Reviewer of the Month (2025)

In 2025, GS reviewers continue to make outstanding contributions to the peer review process. They demonstrated professional effort and enthusiasm in their reviews and provided comments that genuinely help the authors to enhance their work.

Hereby, we would like to highlight some of our outstanding reviewers, with a brief interview of their thoughts and insights as a reviewer. Allow us to express our heartfelt gratitude for their tremendous effort and valuable contributions to the scientific process.

Read More>>

Interviews with Outstanding Authors (2025)

In 2025, many GS authors make outstanding contributions to our journal. Their articles published with us have received very well feedback in the field and stimulate a lot of discussions and new insights among the peers.

Hereby, we would like to highlight some of our outstanding authors who have been making immense efforts in their research fields, with a brief interview of their unique perspective and insightful view as authors.

Read More>>

Welcome Prof. Bin Ouyang being the New Associate Editor-in-Chief of Gland Surgery

The editorial office of Gland Surgery is pleased to announce that, effective February 21, 2025, Prof. Bin Ouyang will become the new Associate Editor-in-Chief of Gland Surgery.

We are excited to have Prof. Ouyang in the position to build on the work of the current editors and to add brilliance to GS, and for the journal to reach new heights.

We wish Prof. Ouyang every success in her editorial work for GS.

Read More>>

2024 Annual Report of GS

Greetings from the Editorial Office of GS!

We are pleased to share the 2024 Annual Report of Gland Surgery.

We would especially like to express our sincere gratitude to the editorial board members, guest editors, reviewers, authors and readers for all your support and contributions to GS.

We wish you a happy, healthy and prosperous 2025!

GS Editorial Office

Read More>>

Interviews with Editorial Board Members

GS features a distinguished editorial board, the members of which continue to instill the power of their expertise for the journal’s development. By launching this column, we are glad to introduce to you some of them in the form of interviews, in which they will share their unique career experiences and perspectives. We believe their insights will shed light on the knowledge of related fields.

Read More>>

Interviews with Guest Editors

Over the years, a number of GS guest editors have made valuable contributions to the journal. This column features interviews with our guest editors, who graciously share their experience in scientific careers and provide insightful perspectives on the special series.

Read More>>

Use of choline PET and ultrasound for preoperative localization of hyperfunctioning parathyroid glands: a single-institution retrospective cohort study

Confusion matrix comparing number of abnormal parathyroid glands identified on choline PET (above) and ultrasound (below) vs. number of removed parathyroid glands during subsequent surgery. Blue indicates matching number of observations and pink indicates discrepancies. Darker color indicates higher count. All 50 operated patients underwent a preoperative PET scan, but only 46 underwent an ultrasound. PET, positron emission tomography.

Read More>>

Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection

The relationship of ND with first recurrence site and RFS, and the time to recurrence. (A) Scatter plots of ND according to the first recurrence site. ND was significantly higher in cases of local/lymph node recurrence(s) compared to hematogenous recurrence(s). Two patients experienced simultaneous hematogenous and lymph node recurrence. The box represents the median and upper/lower quartiles. (B-D) Cumulative recurrence rates among patients with recurrence in each group at the most recent visit; (B) all cases with recurrence(s) (the cutoff of ND 17.4%), (C) CND-only group with recurrence(s) (the cutoff of ND 38.9%), and (D) LND group with recurrence(s) (the cutoff of ND 34.2%). In all three groups, patients with higher ND than the cutoffs showed earlier recurrence, compared to those with lower ND

Read More>>

Intrathyroidal parathyroid carcinoma masquerading as a cystic thyroid nodule: a case report

USG of thyroid shows two well defined TIRADS 1 thyroid nodules measuring 1.7 cm × 2.3 cm × 1.6 cm (A) and 2.3 cm × 3.2 cm × 3.1 cm (B), with no worrisome features. TIRADS, thyroid imaging, reporting and data system; USG, ultrasound.

Read More>>

Which is the best surgical approach for thymectomy: robot-assisted thoracoscopic surgery (RATS), video-assisted thoracoscopic surgery (VATS), thoracotomy (TORA) or subxiphoid video-assisted thoracoscopic surgery (SPT)?—a systematic review and network meta-analysis

Clustered ranking plots based on SUCRA values of perioperative outcomes with different surgical approaches. (A) Operative time. (B) Blood loss. (C) Pleural drainage duration. (D) Pleural drainage volume. (E) Duration of hospital stay. (F) ICU stay. (G) Postoperative complications. POD1, postoperative day 1; RATS, robot-assisted thoracoscopic surgery; SPT, subxiphoid video-assisted thoracoscopic surgery; SUCRA, surface under the cumulative ranking; TORA, thoracotomy; VAS, visual analogue scale; VATS, video-assisted thoracoscopic surgery.

Read More>>